Journal of Antimicrobial Chemotherapy

Article	Citations
Correction to: Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomon	184
Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy	125
Correlation between rrs gene mutations and amikacin resistance in Mycobacterium abscessus: implications for fitness cost and clinical prevalence	99
Indolocarbazoles as host-directed therapeutics against intracellular infections by methicillin-resistant Staphylococcus aureus	95
Antimony used as rescue therapy in a kidney transplant recipient unresponsive to liposomal amphotericin B for chronic visceral leishmaniasis	73
Correction to: Phenotypic and genotypic analysis of antimicrobial resistance in Nocardia species	67
β-Lactam concentrations monitored in the early phase of community-acquired sepsis in the intensive care unit	63
Despite increasing use of integrase inhibitors to treat HIV infection, resistance to this class remains stable	62
Liposomal amikacin and Mycobacterium abscessus: intimate interactions inside eukaryotic cells	59
Establishment of epidemiological cut-off values of etimicin: a new fourth-generation aminoglycoside, against Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudom	55
Microdialysis assessment of gentamicin for second-line antimicrobial prophylaxis in abdominal surgery	52
Model-based translation of results from in vitro to in vivo experiments for afabicin activity against Staphylococcus aureus	51
Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection	50
Fatal invasive pulmonary and cerebral aspergillosis due to triazole-resistant Aspergillus fumigatus with multiple CYP51A mutations	49
Prosthetic joint infections: 6 weeks of oral antibiotics results in a low failure rate	49
Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study	45
Molecular mechanism of envZ regulating β-lactam antibiotic resistance and virulence in Escherichia coli	45
Short-cycle three-day-per-week efavirenz/emtricitabine/tenofovir disoproxil fumarate therapy: a seven-year extension study	44
Distinct molecular epidemiology of resistances to extended-spectrum cephalosporins and carbapenems in Enterobacter hormaechei in cats and dogs versus horses in France	44
Antimicrobial use for the treatment of bacterial sexually transmitted infections among doxycycline post-exposure prophylaxis (DoxyPEP) users in Milan, Italy—right-to-reply	43
Management and outcomes of Stenotrophomonas maltophilia recovered from deep-site clinical specimens: a bicentric retrospective cohort study	43
Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime–avibactam in a case series of orthotopic liver transplant recipients	43
Risk factors for suboptimal target attainment of commonly used ß-lactam antibiotics in older adults: a prospective cohort study	42
Emergence of the mobile RND-type efflux pump gene cluster tmexCD1-toprJ1 in Klebsiella pneumoniae clinical isolates in Japan	42
Epidemiology and clinical relevance of persistent bacteraemia in patients with Gram-negative bloodstream infection: a retrospective cohort study	42

Overcoming antimicrobial resistance in Helicobacter pylori: the roles of collateral sensitivity and biofilm dynamics	41
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate	40
NDM-5-producing Klebsiella pneumoniae ST258 in a university hospital in Argentina	40
Multicentre investigation of Wickerhamomyces anomalus fungemia in India: emerging resistance and mechanistic insights	39
Genomic and transcriptomic variation in Bordetella spp. following induction of erythromycin resistance	38
Emergence of a novel tet (X5) variant in Klebsiella spp. isolated from retail meat in Hainan, China	37
Harnessing metabolic dependence-driven antibiotic synergy to eradicate tolerant Pseudomonas aeruginosa	34
Genomic insights into the tmexCD-toprJ : plasmid-mediated evolution, dissemination and diversity in bacterial populations	34
Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco	34
The impact of palliative care consultation on reducing antibiotic overuse in hospitalized patients with terminal cancer at the end of life: a propensity score-weighting study	34
Uropathogenic Escherichia coli population structure and antimicrobial susceptibility in Norfolk, UK	34
Point-of-care tests to manage acute respiratory tract infections in primary care: a systematic review and qualitative synthesis of healthcare professional and patient views	33
Exploring the pharmacokinetic mechanisms that affect bictegravir exposure during pregnancy	33
Systematic review on oral antibacterial relay therapy for acute staphylococcal prosthetic joint infections treated with debridement, antibiotics and implant retention (DAIR)	33
Dynamic CSF metagenomic next-generation sequencing to guide duration of therapy in Listeria monocytogenes ventriculitis: a multi-modal strategy with intr	33
Pharmacokinetics and pharmacogenetics of high-dosage tedizolid for disseminated nocardiosis in a lung transplant patient	33
Conventional versus extended-pulsed fidaxomicin dosing in patients at high risk of recurrence ofClostridioides difficileinfection: a propensity score analysis	32
SQ31f is a potent non-tuberculous mycobacteria antibiotic by specifically targeting the mycobacterial F-ATP synthase	32
Off-label use of dalbavancin in children: a case series	32
Phenotypic and genotypic antimicrobial susceptibility patterns of the emerging human respiratory pathogen Mycoplasma amphoriforme isolated from the UK and Denmark	30
Antibacterial activity of propylene glycol against Staphylococcus aureus and Staphylococcus epidermidis in neutral and mild acidic conditions	30
General practice antibiotic prescriptions attributable to respiratory syncytial virus by age and antibiotic class: an ecological analysis of the English population	30
Ultra-rapid selection of the N74D capsid inhibitor resistance mutation after 3 weeks on lenacapavir	30
Correction to: Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV	29
Antibiotic biocompatibility assay and anti-biofilm strategies for Pseudomonas aeruginosa infection in bioengineered artificial skin substitutes	29
Plasmodium falciparum isolates: ex vivo drug response	29
Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with pipera	29
Evaluation of the RESIST ACINETO multiplex immunochromatographic assay for detection of OXA-23-like, OXA-40/58-like and NDM carbapenemase production in Acinetobacter baumannii	29
Oral antimicrobial agents in patients with short bowel syndrome: worth a try!—authors’ response	29
Effect of empiric antibiotics against Pseudomonas aeruginosa on mortality in hospitalized patients: a systematic review and meta-analysis—authors’ response	29
Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginos	29
Effect of different strategies for excluding duplicate cultures on the correlation between hospital resistance rates and antibiotic consumption	28
Comment on: Community-acquired pneumonia: a US perspective on the guideline gap	28
In vitro activity of gepotidacin against a challenging panel of multidrug-resistant Neisseria gonorrhoeae isolates	28
Streptococcus suisprophage lysin as a new strategy for combating streptococci-induced mastitis andStreptococcus suisinfection	28
Synergistic effects of quorum-sensing molecules and antimicrobials against Candida albicans and Pseudomonas aeruginosa biofilms: in vitro and in vivo studies	27
Assessment of co-resistance to antibiotics recommended for acute pyelonephritis among Escherichia coli clinical strains from community- and nursing home–acquired urinary tract infections	27
Plasma protein binding of ceftriaxone in critically ill patients: can we predict unbound fractions?	27
Reporting England’s progress towards the ambitions in the UK action plan for antimicrobial resistance: the English surveillance programme for antimicrobial utilisation and resistance (ESPAUR)	27
In vitro activity of thiamphenicol against drug-susceptible and drug-resistant strains of Mycoplasma genitalium	27
Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniae	27
Investigating the cause of increased tetracycline-resistant Neisseria gonorrhoeae in England, 2016–20	26
Results from the Survey of Antibiotic Resistance (SOAR) 2018–21 in Türkiye: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints	26
Antibiotic-induced degradation of antitoxin enhances the transcription of acetyltransferase-type toxin-antitoxin operon	26
Novel mutations associated with clofazimine resistance in Mycobacterium intracellulare	26
Leveraging interdisciplinary management in people with HIV and lymphoid neoplasms	26
Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort	25
Genomic analysis reveals the population structure and antimicrobial resistance of avian Pasteurella multocida in China	25
Effect of methenamine hippurate shortage on antibiotic prescribing for urinary tract infections in Norway—an interrupted time series analysis	25
Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022	25

Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions	25
Impact of COVID-19-related healthcare changes on antibiotic resistance in clinical Escherichia coli isolates: interrupted time series analyses in Scotlan	25
Safety of topical tobramycin powder during operative treatment of fractures	25
Pharmacokinetics and optimized dosing of dispersible and non-dispersible levofloxacin formulations in young children	25
Effect of adjunctive inhalation on the association between plasma AUC/MIC of polymyxin B and clinical efficacy in MDR gram-negative infections	24
Outcomes after heart valve surgery for adult patients with active Enterococcus faecalis infective endocarditis: a 20-year, national, retrospective, obser	24
Liver cyst penetration of antibiotics at the target site of infection: a randomized pharmacokinetic trial	24
External quality assurance (EQA) network in South and South-East Asia: experience and results from an international EQA programme in One Health sector reference laboratories	24
A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection	24
Oritavancin in a patient with recurrent endocarditis by Enterococcus faecalis: a new therapeutic option?	23
Evaluation of fidaxomicin use in patients with a macrolide allergy/intolerance	23
Plasma concentration of orally administered amoxicillin and clindamycin in patients receiving haemodialysis	23
Unnoticed spread of linear VanA-plasmids in vancomycin-variable Enterococcus faecium strains across different regions: a diagnostics challenge	23
Model-based translation of the PKPD-relationship for linezolid and vancomycin on methicillin-resistant Staphylococcus aureus: from in vitro time–kill experiments to a mouse pneumonia mod	23
A scoring system to predict resistance to ceftolozane/tazobactam in respiratory isolates of Pseudomonas aeruginosa	23
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review	23
Characterization of a multiresistance optrA- and lsa(E)-harbouring unconventional circularizable structure in Streptococcus suis	23
The acquisition of transferable extrachromosomal fec operon is associated with a cefiderocol MIC increase in Enterobacterales	23
Development and evaluation of a novel rapid immunochromatographic assay for the detection of DHA-producing Enterobacterales	23
Clinical aspects and recent advances in fungal diseases impacting human health	22
Systematic review of antimicrobial pharmacokinetic/pharmacodynamic indices in murine thigh and hollow fibre dose fractionation studies analysed with a standard method	22
In vitro and in vivo antibacterial activity, resistance analysis and molecular docking study of pleuromutilin derivatives against Streptococcus suis	22
Temocillin efficacy against AmpC β-lactamase-producing Enterobacterales: a relevant alternative to cefepime?	22
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry	22
Tn 7860 , a novel chromosomal pseudo-compound transposon carrying the OptrA gene in	22
Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study	22
Subcutaneously administered antibiotics: a review (addendum)	22
Comment on: Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study	22
Validation of the Antifungal National Antimicrobial Prescribing Survey (AF-NAPS) quality assessment tool	21
Eligibility and factors associated with long-acting injectable cabotegravir-rilpivirine initiation in an urban academic HIV clinic	21
Prevalence of drug resistance mutations in low-level viremia patients under antiretroviral therapy in Southwestern China: a cross-sectional study	21
Phenotypic and genotypic characterization of HMB-3, a metallo-beta-lactamase from Pseudomonas asiatica	21
Pharmacokinetic/pharmacodynamic model-based optimization of temocillin dosing strategies for the treatment of systemic infections	21
Population pharmacokinetics of posaconazole in allogeneic haematopoietic stem cell transplant patients	21
Appropriateness of virological monitoring with long-acting injectable cabotegravir and rilpivirine	21
Correction to: Pharmacokinetics of anti-TB drugs in children and adolescents with drug-resistant TB: a multicentre observational study from India	21
Stability of temocillin in outpatient parenteral antimicrobial therapy: is it a real option?	21
The magnitude of the pharmacodynamic index for NOSO-502: pathogen clearance, emergence of resistance and human dose predictions	21
Clinical, pharmacological, and qualitative characterization of drug–drug interactions in pregnant women initiating HIV therapy in Sub-Saharan Africa	21
Uptake of drug-reduced antiretroviral strategies and impact on costs over 2015–22: experience from an HIV clinic in Paris, France	20
Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia	20
Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV	20
Comment on: Distinct population structure and genomic context of NarAB between broiler and human clinical Enterococcus isolates	20
Performance of disc diffusion and gradient strip test on different Mueller–Hinton agar media plates and ComASP® and Bruker UMIC® Cefiderocol Microdilution Panels for cefiderocol susceptibility testing	20
Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy	20
GyrB in silico mining in 27 151 global gonococcal genomes from 1928–2021 combined with zoliflodacin in vitro testing of 71 international gonococcal isolates with different GyrB, ParC and	20
Population pharmacokinetics of aciclovir and its major metabolite 9-carboxymethoxymethylguanine and safety profile of valaciclovir in early liver transplant recipients	20
Changes in NNRTI use have not altered the ecology of NNRTI resistance over the last 10 years in people with HIV experiencing virological failure on antiretroviral drugs	20
Usefulness of inclusion of ertapenem and temocillin screening breakpoints in the EUCAST rapid antimicrobial susceptibility testing (RAST) for rapid detection of OXA-48-producing Klebsiella pneumoni	20
Population pharmacokinetics of bictegravir in real-world people with HIV	20
Comparison of disk diffusion, MIC test strip and broth microdilution for eravacycline susceptibility testing of 422 Staphylococcus aureus isolates using	20
Off-label oritavancin treatment outcome and molecular characterization of a vancomycin- and linezolid-resistant Enterococcus faecium causing liver abscesses	20
The association between bacteriuria and adverse pregnancy outcomes: a systematic review and meta-analysis of observational studies	20
In vitro activity of aztreonam in combination with newly developed β-lactamase inhibitors against MDR Enterobacterales and Pseudomonas aeruginosa producing metallo-β-lactamases	20
Establishment of RCPA national guidelines for selective reporting of antimicrobials: processes, challenges and measuring the impact	19
Pristinamycin-induced sideroblastic anaemia	19
Diagnostic uncertainties in patients with bacteraemia: impact on antibiotic prescriptions and outcome	19
A disproportionality analysis of adverse events associated with omadacycline based on the FDA adverse event reporting system database	19
Swedish multicentre study of target attainments with β-lactams in the ICU: which MIC parameter should be used?	19
Influence of a putative TonB-dependent receptor on cefiderocol susceptibility in clinical Enterobacter hormaechei isolates	19
Temporal trends in antibiotic prescribing and serious and nonserious infections in children presenting to general practice: a registry-based longitudinal cohort study of 162 507 individuals	19
Investigation of genomic mutations and their association with phenotypic resistance to new and repurposed drugs in Mycobacterium tuberculosis complex clinical isolates	19
Surveillance of antimicrobial resistant Shiga toxin-producing E. coli O157:H7 in England, 2016–2020	19
Validation of a modified rapid test to detect the cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus from bloodstream infections in hospitals from North and Latin Americ	19
In vitro activity of fosfomycin against bacterial pathogens isolated from urine specimens in Canada from 2007 to 2020: CANWARD surveillance study	19
A multi-site, international laboratory study to assess the performance of penicillin susceptibility testing of Staphylococcus aureus	19
Genetic determinants of resistance to antimicrobial therapeutics are rare in publicly available Clostridioides difficile genome sequences	19
Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015–20	19
Efficacy of favipiravir against influenza virus resistant to both baloxavir and neuraminidase inhibitors	19
The antiplasmodial activity of the carboxylic acid metabolite of piperaquine and its pharmacokinetic profiles in healthy volunteers	18
Decreased cyclic-AMP caused by ATP contributes to fosfomycin heteroresistance in avian Escherichia coli	18
Influence of ultrafiltration conditions on the measurement of unbound drug concentrations: flucloxacillin as an example	18
Impact of removing ESBL status labelling from culture reports on the use of carbapenems for non-bacteraemic patients diagnosed with ESBL-positive urinary tract infections	18
Diffusion of amoxicillin into heart valves from infective endocarditis patients	18
Correction to: Linezolid brain penetration in neurointensive care patients	18
Interventions to improve antibiotic use among dentists: a systematic review and meta-analysis	18
Evaluation of publication bias for 12 clinical trials of molnupiravir to treat SARS-CoV-2 infection in 13 694 patients with meta-analysis	18
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011–2020	18
Correction to: In vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Surveillance Program	18
Co-existence of the oxazolidinone resistance genes cfr and optrA on a novel multiresistance plasmid from a	18

Preface	18
Antibiotic use by clinical presentation across all healthcare providers in rural Burkina Faso: a healthcare visit exit survey	18
Impact of veterinary antibiotics on plasmid-encoded antibiotic resistance transfer	18
Simulated exposures of oritavancin in in vitro pharmacodynamic models select for methicillin-resistant Staphylococcus aureus with reduced susceptibility to oritavancin but minimal cross-	18
Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients—authors’ response	18
In vitro activity of ceftobiprole plus ampicillin against Enterococcus faecalis causing infective endocarditis: phenotypic and genotypic characterization	17
Correction to: Systematic reviews and the Journal of Antimicrobial Chemotherapy; past, present and future. A systematic reappraisal	17
Trends in fluoroquinolone prescribing in UK primary and secondary care between 2019 and 2023	17
In vitro activity of delafloxacin against clinical levofloxacin-resistant Helicobacter pylori isolates	17
Carbapenem resistance in Enterobacterales bloodstream infections among children with cancer or post-haematopoietic stem cell transplant: a retrospective cohort study	17
Raising awareness of antimicrobial resistance: development of an ‘antibiotic footprint calculator’	17
Is cefazolin an option for treatment of staphylococcal endogenous endophthalmitis?	17
Prevalence and associated factors of antibiotic exposure during pregnancy in a large French population-based study during the 2010–19 period	17
Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a patient with HIV infection treated with bictegravir/tenofovir alafenamide/emtricitabine: case report and review of the	17
Antimicrobial use for the treatment of bacterial sexually transmitted infections among doxycycline post-exposure prophylaxis (DoxyPEP) users in Milan, Italy	17
Clinical impact of time to results from the microbiology laboratory in bloodstream infections caused by carbapenemase-producing Enterobacterales (TIME-CPE STUDY)	17
Optimal dosing of amoxicillin in obese and post-gastric bypass patients using a population pharmacokinetics-pharmacodynamics model approach	17
Epidemiology and treatment of endocarditis secondary to Enterobacterales other than Serratia spp.	17
Results from the Survey of Antibiotic Resistance (SOAR) 2018–21 in Pakistan: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints	17
The pharmacokinetics/pharmacodynamics of ceftazidime/avibactam for central nervous system infections caused by carbapenem-resistant Gram-negatives: a prospective study	17
BMHC-1: a novel chromosomally encoded metallo-β-lactamase with potent carbapenemase activity and potential for global dissemination in zoonotic and human pathogens	16
In vivo evaluation of cefazolin inoculum effect in the treatment of experimental Staphylococcus aureus pneumonia with cefazolin	16
Genomic characterization of colistin heteroresistance in Acinetobacter baumannii : Evidence for lpxD delet	16
Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa	16
In vitro activity and genomic characterization of KPC-producing Klebsiella pneumoniae clinical blood culture isolates resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/	16
Insights from the WHO Tricycle-aligned Fleming Fund EQASIA External Quality Assessment (EQA) programme detecting ESBL-, AmpC- and carbapenemase-producing Escherichia coli	16
Dynamics of dual CMV and EBV co-reactivation and emergence of resistance in an HSCT recipient	16
Genomic comparison of mecC-carrying methicillin-resistant Staphylococcus aureus from hedgehogs and humans in the Netherlands	16
Cefepime–taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018–22	16
Comparative evaluation of early treatment with ceftolozane/tazobactam versus ceftazidime/avibactam for non-COVID-19 patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa	16
Early targeted therapy guided by rapid phenotypic antimicrobial susceptibility testing in critically ill patients with Gram-negative bacterial bloodstream infections: a retrospective cohort study	16
Refractory versus resistant invasive aspergillosis	16
Identification of vancomycin exposure target in neonates: how much is enough?	16
Changing epidemiology of MRSA-CC398 in Spanish hospitals located in areas with different pig farming densities: a 2023 multicentre study	16
Coccidioidomycosis in Europe: a systematic literature review of epidemiology, treatment and outcomes	16
Temocillin versus other intravenous beta-lactams for urinary tract infections caused by third-generation cephalosporin-resistant Enterobacterales: a multicentre retrospective matched cohort study	16
Efficacy of meropenem against ceftazidime–avibactam-resistant Klebsiella pneumoniae producing KPC-31, KPC-33, KPC-90, KPC-106 and KPC-114	16
In vitro dynamics and mechanisms of cefiderocol resistance development in wild-type, mutator and XDR Pseudomonas aeruginosa	16
Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections	16
The veterinary clinic backyard lawn used for relief walks of hospitalized dogs is a hotspot for OXA-type carbapenemases in multiple Enterobacterales	16
Helicobacter pylori culture positivity and antimicrobial susceptibility profiles (Vancouver, Canada)	16
Carbapenem combination therapy versus standard of care for persistent methicillin-susceptible Staphylococcus aureus bacteraemia	16
Efficacy of oleylphosphocholine in experimental cutaneous leishmaniasis	16
Antibiotic prescription patterns during last days of hospitalized patients with advanced cancer: the role of palliative care consultation	16
A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalized patients during the first wave of COVID-19	15
Treatment of persistent focalized Q fever: time has come for an international randomized controlled trial	15
Effect of pretreatment HIV drug resistance on mortality, attrition and viral suppression in patients initiating antiretroviral therapy and genetic transmission network: an observational cohort study i	15
Antimicrobial activity of aztreonam–avibactam against KPC variant-producing Klebsiella pneumoniae with ceftazidime–avibactam resistance	15
Optimization and improvement of the disc diffusion method for mucoid Pseudomonas aeruginosa	15
Fluoroquinolones in orthopaedic infection: balancing risks and rewards	15
Activity of rezafungin against Candida auris	15
Strengthening antimicrobial resistance diagnostics in National Reference Laboratories across One Health in South and Southeast Asia: impact of external quality assessment and targeted follow-up	15
Foreword	15
Quantitative performance of humanized plasma and epithelial lining fluid exposures of meropenem, cefiderocol and tobramycin against a challenge set of Klebsiella pneumoniae and Pseudomonas a	15
Class 1 DISARM system in restriction of conjugative carbapenemase-encoding plasmids in Klebsiella pneumoniae sequence type 23	15
Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a Tertiary University Hospit	15
Effect of albumin substitution on pharmacokinetics of piperacillin/tazobactam in patients with severe burn injury admitted to the ICU	15
Gepotidacin: a novel, oral, ‘first-in-class’ triazaacenaphthylene antibiotic for the treatment of uncomplicated urinary tract infections and urogenital gonorrhoea	15
Professor Alasdair Macintosh Geddes, 14 May 1934–9 April 2024	15
Emergence of mcr-8.1 gene coexisting with blaNDM in Citrobacter werkmanii isolated from a chicken farm in China	15
Repurposing antimalarials: pyrimethamine exhibits superior in vitro activity to metronidazole against Gardnerella while sparing Lactobacillus	15
Evaluation of an optimized intermittent vancomycin dosing regimen in infants	15
Local antibiotic resistance surveillance in nursing homes using lot quality assurance sampling: a feasibility study	15
Exploring the in situ evolution of nitrofurantoin resistance in clinically derived uropathogenic Escherichia coli	15
JAC Supplement: ‘faster ID and AST revolution: how to improve antibiotic use in the critically ill’	15
Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial	14
Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma	14
Towards optimizing carbapenem selection in stewardship strategies: a prospective propensity score-matched study of ertapenem versus class 2 carbapenems for empirical treatment of third-generation ceph	14
Population pharmacokinetics and CSF penetration of flucytosine in adults with HIV-associated cryptococcal meningoencephalitis	14
Hospitalizations and severe complications following acute sinusitis in general practice: a registry-based cohort study	14
Association between seasonal influenza vaccination and antimicrobial use in Japan from the 2015–16 to 2020–21 seasons: from the VENUS study	14
Influence of factors commonly known to be associated with health inequalities on antibiotic use in high-income countries: a systematic scoping review	14
Ceftaroline and ceftobiprole monotherapy for the treatment of Staphylococcus aureus infections: a systematic review and Bayesian meta-analysis	14
In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species	14
Rapid detection of CTX-M-type ESBLs and carbapenemases directly from biological samples using the BL-DetecTool	14
Comparison of prophylactic antibiotics for endonasal transsphenoidal surgery using a national inpatient database in Japan	14
Evaluating hypoalbuminaemia thresholds associated with delayed blood sterilization among patients receiving cefazolin or antistaphylococcal penicillins for MSSA bacteraemia	14
Correction to: Up-regulation of silent information regulator 2 (Sir2) is associated with amphotericin B resistance in clinical isolates of Leishmania donovani	14
Phenotypic and genetic characterization of antimicrobial resistance inSalmonella entericaserovar Choleraesuis isolates from humans and animals in Spain from 2006 to 2021	14
Phenotype–genotype discordance in antimicrobial resistance profiles of Gram-negative uropathogens recovered from catheter-associated urinary tract infections in Egypt	14
Evolving landscape of methicillin-resistant Staphylococcus pseudintermedius : the emergence of new epidemic waves across Europe, Asia and North America	14
Pharmacokinetics of cefazolin in bariatric surgery patients: a preoperative perspective	14
Increasing rates of ESBL-producing Escherichia coli and Klebsiella pneumoniae in Canadian Hospitals: 17 years of the CANWARD study, 2007–23	14
Subinhibitory concentration of clarithromycin targets SaeR to reduce the haemolytic activity of Staphylococcus aureus	14
Correction to: The long walk to a short half-life: the discovery of augmented renal clearance and its impact on antibiotic dosing	14
Association between antimicrobial usage in livestock and antimicrobial resistance in Escherichia coli isolates from human urinary tract infections in the Netherlands, 2009–2020	14
Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life setting	14
Pharmacokinetic and pharmacodynamic properties of polymyxin B in Escherichia coli and Klebsiella pneumoniae murine infection models	14
High azole non-wild type rates and nosocomial microsatellite typing aggregation of Wickerhamomyces anomalus in China according to a 12-year multicenter surveillance study	13
Molecular ecology of highest priority critically important antibiotic resistant Escherichia coli from mammals housed at an urban zoo	13
Depolymerase as a potent adjunct to polymyxin for targeting KL160 pandrug-resistant Acinetobacter baumannii in a murine bacteremia model	13
Relative bioavailability of crushed tebipenem administered through a nasogastric tube with and without enteral feeding	13
Lung toxicity related to trimethoprim/sulfamethoxazole: pharmacovigilance data review	13
The emerging clinical relevance and antimicrobial resistance of Pluralibacter gergoviae : a systematic review	13
Pharmacokinetics of colistin in adult critically ill patients in South Africa	13